A diverse range of gene products are effectors of the type I interferon antiviral response

被引：0
|
作者：
John W. Schoggins
Sam J. Wilson
Maryline Panis
Mary Y. Murphy
Christopher T. Jones
Paul Bieniasz
Charles M. Rice
机构：
[1] Laboratory of Virology and Infectious Disease,
[2] Center for the Study of Hepatitis C,undefined
[3] The Rockefeller University,undefined
[4] Howard Hughes Medical Institute,undefined
[5] Laboratory of Retrovirology,undefined
[6] Aaron Diamond AIDS Research Center,undefined
[7] The Rockefeller University,undefined
来源：
Nature | 2011年 / 472卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
There is growing interest in antiviral interferon-stimulated genes (ISGs), such as IFITM3 and BST2 (also known as tetherin), because of their potential as drug targets. An overexpression screen has been used to assess the impact of several hundred ISGs on the replication of a number of viruses, including HIV-1 and hepatitis C virus. Combinations of validated antiviral ISGs were found to have additive effects and to converge on translational inhibition. Surprisingly, some ISGs actually enhance the replication of certain viruses, underlining the complexity of the response to interferon.
引用
收藏
页码：481 / 485
页数：4
相关论文
共 50 条
  • [21] The Role of Optineurin in Antiviral Type I Interferon Production
    Outlioua, Ahmed
    Pourcelot, Marie
    Arnoult, Damien
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [22] Fueling Type I Interferonopathies: Regulation and Function of Type I Interferon Antiviral Responses
    Ng, Chen Seng
    Kato, Hiroki
    Fujita, Takashi
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (07): : 383 - 392
  • [23] The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19
    Suzzi, Stefano
    Tsitsou-Kampeli, Afroditi
    Schwartz, Michal
    NATURE IMMUNOLOGY, 2023, 24 (02) : 220 - 224
  • [24] The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19
    Stefano Suzzi
    Afroditi Tsitsou-Kampeli
    Michal Schwartz
    Nature Immunology, 2023, 24 : 220 - 224
  • [25] FAT10 is phosphorylated by IKKβ to inhibit the antiviral type-I interferon response
    Saxena, Kritika
    Roverato, Nicola Domenico
    Reithmann, Melody
    Mah, Mei Min
    Schregle, Richard
    Schmidtke, Gunter
    Silbern, Ivan
    Urlaub, Henning
    Aichem, Annette
    LIFE SCIENCE ALLIANCE, 2023, 7 (01)
  • [26] TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense
    Wang, Ling
    Ning, Shunbin
    VIRUSES-BASEL, 2021, 13 (02):
  • [27] Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response
    Cosset, Erika
    Petty, Tom J.
    Dutoit, Valerie
    Cordey, Samuel
    Padioleau, Ismael
    Otten-Hernandez, Patricia
    Farinelli, Laurent
    Kaiser, Laurent
    Bruyere-Cerdan, Pascale
    Tirefort, Diderik
    El-Dusouqui, Soraya Amar
    Nayernia, Zeynab
    Krause, Karl-Heinz
    Zdobnov, Evgeny M.
    Dietrich, Pierre-Yves
    Rigal, Emmanuel
    Preynat-Seauve, Olivier
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) : 1381 - 1389
  • [28] Establishment of a CRISPR/Cas9 knockout library for screening type I interferon-inducible antiviral effectors in pig cells
    Dang, Wen
    Li, Tao
    Xu, Fan
    Wang, Yannan
    Yang, Fan
    Zheng, Haixue
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Phleboviruses and the Type I Interferon Response
    Wuerth, Jennifer Deborah
    Weber, Friedemann
    VIRUSES-BASEL, 2016, 8 (06):
  • [30] Early antiviral type I interferon impairs lung metastasis
    Jeena, Lisha
    Gea-Mallorqui, Ester
    NATURE REVIEWS IMMUNOLOGY, 2025,
12345